JX Luxventure Group Inc. (JXG) — Institutional Holders, Q1 2026
1 institutional investment managers reported a JXG position on SEC Form 13F-HR for the quarter ended March 31, 2026, with a combined reported value of $139.00. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
JXG in Q1 2026: what funds did
Funds that filed a 13F for both Q4 2025 and Q1 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
None this quarter.
Biggest sellers
- MORGAN STANLEYSold out · -745 sh-$2.8K
- UBS Group AGTrimmed · -663 sh-$2.5K
JXG 13F holders ranked 1–1 of 1
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q4 2025 |
|---|---|---|---|---|---|
| 1 | UBS Group AG#1 · 37 sh | 37 | $139.00 | — | -94.7% |
Funds that sold out of JXG in Q1 2026 (2)
Held JXG at the end of Q4 2025 and filed a Q1 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q4 2025 |
|---|---|---|
| MORGAN STANLEY745 sh | 745 | $4.5K |
| HRT FINANCIAL23,213 sh | 23,213 | $139.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q1 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q4 2025 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.